Knowledge about Administration and Regulation of High Alert Medication among Nurses in Oncology Department

Main Article Content

Shifra Aziz
Humaira Saddique
Syeda Sidra Tasneem


Background: High alert medications (HAMs) are associated with a higher risk of causing significant patient harm when used in error. Understanding the administration and regulation of these medications within oncology settings is critical due to the complex nature of cancer treatment regimens and the severity of potential medication errors.

Objective: To assess the knowledge of nurses regarding the administration and regulation of high alert medications in an oncology department of a tertiary care hospital.

Methods: A descriptive cross-sectional study was conducted among 133 registered nurses in the oncology department of Jinnah Hospital, Lahore. Data were collected using a structured questionnaire designed to evaluate nurses' knowledge of HAMs. Participants included both male (29.3%) and female (70.7%) nurses, with varying educational backgrounds and work experiences. Statistical analysis was performed using SPSS version 25, focusing on descriptive statistics such as frequencies, percentages, means, and standard deviations.

Results: The results revealed moderate knowledge levels among nurses with significant gaps in critical areas. Only 20.3% correctly identified the protocol for fast IV push of 1:1000 epinephrine in mild allergic reactions, and 33.8% mistakenly believed that 10% calcium gluconate and 10% calcium chloride were interchangeable. Additionally, 44.4% incorrectly used 'Amp' or 'Vial' for dose expression instead of 'mg' or 'gm', and 53.4% failed to recognize the importance of distinctive labeling on look-alike drugs.

Conclusion: The study highlights the need for enhanced educational programs and standardized protocols to improve the safe administration and regulation of HAMs in oncology settings. Strengthening nurses' knowledge and practices regarding HAMs is essential to reduce medication errors and improve patient outcomes.

Article Details

How to Cite
Aziz, S., Saddique, H., & Tasneem, S. S. (2024). Knowledge about Administration and Regulation of High Alert Medication among Nurses in Oncology Department. Journal of Health and Rehabilitation Research, 4(2), 509–513.
Author Biographies

Shifra Aziz, The Superior University Lahore Pakistan.

BSN (Generic) Student, Department of Nursing, The Superior University Lahore, Pakistan.

Humaira Saddique, The Superior University Lahore Pakistan.

Faculty, Department of Nursing, The Superior University Lahore, Pakistan.

Syeda Sidra Tasneem, The Superior University Lahore Pakistan.

Faculty, Department of Nursing, The Superior University Lahore, Pakistan.


Farag AAM, Eweda SM, Elsayed NF. Nurses Knowledge and Practice in Dealing with High Alert Medications. Alexandria Scientific Nursing Journal. 2017;19(2):1-24.

Barber P, Robertson D. Essentials of Pharmacology for Nurses, 4e. McGraw-Hill Education (UK); 2020.

He M, Huang Q, Lu H, Gu Y, Hu Y, Zhang X. Call for Decision Support for High-Alert Medication Administration Among Pediatric Nurses: Findings From a Large, Multicenter, Cross-Sectional Survey in China. Front Pharmacol. 2022;13:860438.

Labib JR, Youssef MRL, Abd El Fatah SA. High Alert Medications Administration Errors in Neonatal Intensive Care Unit: A Pediatric Tertiary Hospital Experience. Turk J Pediatr. 2018;60(3).

Abd-Elrahman EM, Mostafa GM, Hasanin GG. Effect of an Educational Program for Nurses About High Alert Medications on Their Competence. Benha J Appl Sci. 2022;7(4):273-282.

Ozturk F, Altiparmak O, Torun B, Bektay MY, Sancar M, Okuyan B. Reliability of High-Alert Medications Questionnaire in Turkish Healthcare Professionals. 2022.

Pereira LN, Caon S, Pinto AN, Maciel FH, Sempé TDS, Dal Pizzol TDS. Nurses' Knowledge of High-Alert Medications in a Large-Size University Hospital. Rev Bras Farm Hosp Serv Saude. 2021;12(2):567.

Pierobon N, Batista J, Marcondes L, da Silva DP. Knowledge of Nurses in the Administration and Regulation of High Alert Medications in Oncology. Enfermería Global. 2022;21(3):96-108.

Robinson Wolf Z, Stubin CA, Tait ML, Hughes RG. Best Practices Checklist for Preventing Infusion Errors: Expert Review. Medsurg Nursing. 2022;31(1).

Salman M, Mustafa ZU, Rao AZ, Khan QUA, Asif N, Hussain K, Rashid A. Serious Inadequacies in High Alert Medication-Related Knowledge Among Pakistani Nurses: Findings of a Large, Multicenter, Cross-Sectional Survey. Front Pharmacol. 2020;11:1026.

Salman M, Mustafa ZU, Shehzadi N, Mallhi TH, Asif N, Khan YH, Hussain K. Evaluation of Knowledge and Practices About Administration and Regulations of High Alert Medications Among Hospital Pharmacists in Pakistan: Findings and Implications. Curr Med Res Opin. 2022;38(11):1967-1975.

Toba HA, Samara AM, Zyoud SEH. Nurses’ Knowledge, Perceived Barriers, and Practices Regarding Cancer Pain Management: A Cross-Sectional Study from Palestine. BMC Med Educ. 2019;19(1):1-7.

Younis I, Shaheen N, Bano S. Knowledge & Practice About Administration of High Alert Medication in the Tertiary Care Hospital in Lahore. Int J Health Med Nurs Pract. 2021;3(4):1-16.

Bledsaw K, Prudowsky ZD, Yang E, Harriehausen CX, Robins J, DeJean J, Staton S, Campbell JR, Davis AL, George A, Steffin D. A Novel Oncodental Collaborative Team: Integrating Expertise for Central Line–Associated Bloodstream Infection Prevention in Pediatric Oncology Patients. JCO Oncology Practice. 2023 Jan;19(1):e25-32.

Yousef A, Mohamed W, Ali F, Ali E. Effect of Nursing Education Guidelines About High Alert Medications on Critical Care Nurses' Knowledge and Practices. IOSR J Nurs Health Sci. 2018;7(1):47-54.

Zyoud SEH, Khaled SM, Kawasmi BM, Habeba AM, Hamadneh AT, Anabosi HH, Al-Jabi SW. Knowledge About the Administration and Regulation of High Alert Medications Among Nurses in Palestine: A Cross-Sectional Study. BMC Nurs. 2019;18:1-17.

Beal EW, McNamara M, Owen M, McAlearney AS, Tsung A. Interventions to improve surveillance for hepatocellular carcinoma in high-risk patients: A scoping review. Journal of Gastrointestinal Cancer. 2023 Jun 16:1-4.

Gloy V, Schmitt AM, Düblin P, Hirt J, Axfors C, Kuk H, Pereira TV, Locher C, Caquelin L, Walter‐Claudi M, Lythgoe MP. The evidence base of US Food and Drug Administration approvals of novel cancer therapies from 2000 to 2020. International Journal of Cancer. 2023 Jun 15;152(12):2474-84.

Nguyen JQ, Crews KR, Moore BT, Kornegay NM, Baker DK, Hasan M, Campbell PK, Dean SM, Relling MV, Hoffman JM, Haidar CE. Clinician adherence to pharmacogenomics prescribing recommendations in clinical decision support alerts. Journal of the American Medical Informatics Association. 2023 Jan 1;30(1):132-8.

Wozniewski M, Besheer A, Huwyler J, Mahler HC, Levet V, Sediq AS. A survey on handling and administration of therapeutic protein products in German and Swiss hospitals. Journal of Pharmaceutical Sciences. 2024 Mar 1;113(3):735-43.